Adma Biologics (ADMA) Enterprise Value (2011 - 2025)
Adma Biologics (ADMA) reported Enterprise Value of -$87.6 million for Q4 2025, up 15.04% on a YoY basis from -$76.2 million in Q4 2024, and down 42.75% quarter-over-quarter from -$61.4 million in Q3 2025.
Adma Biologics (ADMA) Enterprise Value (2011 - 2025) Analysis & Trends
Adma Biologics has reported Enterprise Value for 15 years, with the latest figure at -$87.6 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 15.04% year-over-year to -$87.6 million; the trailing twelve-month figure through Dec 2025 stood at -$87.6 million (up 15.04% YoY), and the FY2025 full-year result was -$87.6 million, up 15.04% from the prior year.
- Enterprise Value for Q4 2025 stood at -$87.6 million, down from -$61.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$34.4 million in Q3 2021, with the low at -$103.1 million in Q4 2024.
- Historically, Enterprise Value has averaged -$66.2 million across 5 years, with a median of -$65.9 million in 2023.
- Annual changes were most pronounced in 2021 — Enterprise Value surged 42.34% — and 2023, when it tumbled 112.57%.
- Adma Biologics' Enterprise Value stood at -$51.1 million in 2021, then tumbled by 69.36% to -$86.5 million in 2022, then soared by 40.65% to -$51.4 million in 2023, then sank by 100.86% to -$103.1 million in 2024, then increased by 15.04% to -$87.6 million in 2025.
- The last three Enterprise Value figures came in at -$87.6 million (Q4 2025), -$61.4 million (Q3 2025), and -$90.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | -87.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -87.63 Mn |
| Sep 30, 2025 | -61.39 Mn |
| Jun 30, 2025 | -90.29 Mn |
| Mar 31, 2025 | -71.63 Mn |
| Dec 31, 2024 | -103.15 Mn |
| Sep 30, 2024 | -86.70 Mn |
| Jun 30, 2024 | -88.24 Mn |
| Mar 31, 2024 | -45.30 Mn |
| Dec 31, 2023 | -51.35 Mn |
| Sep 30, 2023 | -74.20 Mn |
| Jun 30, 2023 | -62.51 Mn |
| Mar 31, 2023 | -69.20 Mn |
| Dec 31, 2022 | -86.52 Mn |
| Sep 30, 2022 | -34.91 Mn |
| Jun 30, 2022 | -52.42 Mn |
| Mar 31, 2022 | -69.50 Mn |
| Dec 31, 2021 | -51.09 Mn |
| Sep 30, 2021 | -34.41 Mn |
| Jun 30, 2021 | -42.40 Mn |
| Mar 31, 2021 | -61.97 Mn |